IKT R&D Expenses
Inhibikase Therapeutics Inc · R&D Expenses
IKT R&D Expenses
Latest reported$38.24Mperiod ending
IKT TTM R&D Expenses ($2.90M → $38.24M)
TTM R&D Expenses
High-resolution chart · PNG
IKT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 38,241,214 | |
| 30,118,717 | |
| 29,793,146 | |
| 30,621,242 | |
| 27,161,418 | |
| 24,966,281 | |
| 17,203,981 | |
| 13,019,962 | |
| 12,055,640 | |
| 13,515,508 | |
| 13,618,348 | |
| 13,669,526 | |
| 13,425,628 | |
| 11,872,113 | |
| 12,034,985 | |
| 12,371,085 | |
| 12,543,985 | |
| 11,944,235 | |
| 11,359,104 | |
| 8,195,790 | |
| 5,161,806 | |
| 3,042,548 | |
| 893,802 | |
| 934,773 | |
| 1,069,172 | |
| 1,280,044 | |
| 2,552,711 | |
| 3,745,922 | |
| 4,076,245 | |
| 4,202,319 | |
| 2,903,428 |